MCRS-2026
Translational Research Driving Clinical Advances
March 30-31 & April 1, 2026 ESESCO, Rabat, Morocco
MCRS-2026β
Rationale
Cancer continues to represent a major global health challenge, characterized by complex molecular heterogeneity, dynamic tumor microenvironments, and variable patient responses to therapy. Despite significant progress in understanding oncogenic pathways, epigenetic regulation, and tumor immunology, the translation of fundamental research into clinical interventions remains limited. The Moroccan Cancer Research Society 2026 (MCRS-2026) provides a dedicated platform for integrating basic, translational, and clinical oncology research, fostering interdisciplinary collaboration among molecular biologists, oncologists, bioinformaticians, and healthcare innovators.
Scientific objectives of MCRS'26 include:
- Disseminating cutting-edge discoveries in cancer genomics, proteomics, metabolomics, and immuno-oncology.
- Examining advances in clinical oncology, including adaptive trial designs, biomarker-driven therapies, and integrative patient management.
- Highlight technological innovations: AI, digital pathology, and predictive modelling, such as artificial intelligence, machine learning, and digital pathology, to enhance diagnostics, treatment planning, and patient monitoring.
- Facilitating multidisciplinary exchange through workshops, interactive sessions, and collaborative research networks to accelerate the implementation of evidence-based interventions.
- Promoting translational research that bridges molecular insights with novel therapeutic strategies, including targeted therapies, immunotherapies, and precision medicine approaches.
By convening global experts, MCRS-2026 aims to catalyze the translation of scientific knowledge into effective clinical practice, ultimately improving patient outcomes and advancing the global oncology research agenda. This congress underscores the critical interplay between mechanistic research and clinical application, providing a rigorous scientific forum for the next generation of cancer breakthroughs.
Conference Themes
Cancer Genomics and Precision Medicine
π©Ί Clinical Advances in Oncology π Case Reports in Cancer Care
π Cancer Epidemiology and Disease Trend Mapping
π Career Development for PhD Students and Postdoctoral Researchers
π€ Artificial Intelligence and Digital Health in Cancer Care
𧬠Tumor Immunology and Immunotherapy
βοΈ Ethics in Global Cancer Collaboration
π Translational Oncology and Innovative Cancer Therapies
π§ͺ Early Detection, Screening, and Prevention
π Industry Stands: Innovation in Cancer Care
Conference Sessions
Reserved Sessions
Reserved for high-impact studies submitted shortly before the congress, this session highlights the most recent advances in cancer research. Presentations focused on either clinical, epidemiological, fundamental and translational research are 30 minutes each, including Q&A.
Poster Sessions
Held daily during the congress, poster sessions allow researchers to present their work in an interactive, visual format. Presenters will be available at their posters during scheduled hours to answer questions, discuss findings, and engage with attendees. Selected posters may be considered for awards.
Fire Talks (Quick Shots)
In these fast-paced session, early-career researchers deliver brief 5β8-minute presentations summarizing their findings, followed by a 2β3-minute audience Q&A. This format highlights emerging science and provides a snapshot of diverse topics in cancer research. PhDs and Master students are encouraged to share their research topics.
Case Reports
A platform for clinicians, fellows, and trainees to present unique or complex cases (five or fewer patients) highlighting unusual presentations, rare complications, or innovative approaches. This section also includes Psychology and Nutrition, addressing mental health and dietary challenges in cancer care, and discusses difficulties different countries face in validating treatments internationally, with insights from surgeons on managing such challenges.
Preliminary Program




Location of event
Coordinators

Pr. Lhoussain Hajji
UMI, Meknes, Morocco

Pr. Mouad Edderkaoui
CSMC & UCLA, USA
Honorary committeeβ
Professor Azzedine El Midaoui
Minister of Higher Education, Scientific Research and Innovation, Morocco
Prof. Azzedine El Midaoui is the Minister of Higher Education, Scientific Research and Innovation in Morocco. Before taking on this role, he was the President of Ibn Tofail University in Kenitra from 2014, where he worked to improve the university’s programs and research.
In 2018, he became President of the Conference of Presidents of Moroccan Universities, helping to guide cooperation and planning among the country’s universities. Since 2015, he has also served as a member of the High Council for Education, Training and Scientific Research, contributing to national education policies.
Professor Stephen J. Pandol, MD
Director of Basic and translational Pancreas Research at Cedars-Sinai & Professor of Medicine at UCLA, USA
Professor Pandol leads the American Consortium on Chronic Pancreatitis, Diabetes, and Pancreatic Cancer, driving national efforts to advance understanding and treatment of pancreatic diseases. A former President of the American Pancreas Association, he also serves as Editor of Frontiers in Gastrointestinal Sciences and Associate Editor for several leading journals.
Professor Stephen J. Pandol is an internationally recognized leader in pancreatic physiology and disease. He serves as Director of Basic and Translational Pancreas Research at Cedars-Sinai Medical Centre. He is Professor of Medicine at the University of California, Los Angeles (UCLA), the Cedars-Sinai Medical Centre, and the Charles R. Drew University College of Medicine in Los Angeles.
He has authored over 450 peer-reviewed publications in top-tier journals and holds more than 20 patents related to cancer therapeutics. His groundbreaking work has earned him multiple honours, including two Lifetime Achievement Awards and the Research Mentor Award from the AGA.
Professor Aboubakr Bouayad
President of University Moulay Ismail, Meknes-Morocco
Professeur Aboubakr Bouayad is a prominent Moroccan academic and researcher specializing in Materials Science and Engineering. He currently serves as the Acting President of Moulay IsmaΓ―l University (UMI) in MeknΓ¨s and is a Full Professor at the ENSAM (Γcole Nationale SupΓ©rieure d’Arts et MΓ©tiers) in the same city.
His bibliography reflects a deep expertise in metallurgy, materials processing, and the development of sustainable industrial solutions.
Β
Dr. Salim bin Mohammed Al-Malik
Director-General of the Islamic World Educational, Scientific and Cultural Organization (ICESCO)
Dr. Salim bin Mohammed Al-Malik is a distinguished Saudi leader currently serving as the Director-General of the Islamic World Educational, Scientific and Cultural Organization (ICESCO). A physician by training, he holds a PhD in Medicine from King Saud University and specialized in pediatric allergy and immunology at prestigious institutions in the United States, including Georgetown University. Before transitioning into international diplomacy, he held several high-ranking positions within the Saudi Ministry of Education and the King Faisal Specialist Hospital, establishing himself as a prominent expert in health policy, scientific research, and international academic cooperation.
Since taking office at ICESCO in 2019, Dr. Al-Malik has spearheaded a strategic transformation of the organization under the vision of « The ICESCO We Want.Β Β» He has shifted the institutionβs focus toward digital transformation, the integration of Artificial Intelligence in education, and the global protection of cultural heritage. Under his leadership, ICESCO has become more inclusive and transparent, prioritizing the empowerment of youth and women while fostering cross-civilizational dialogue. His dual background as a scientist and a diplomat allows him to bridge the gap between technical innovation and humanitarian development across the Islamic world and beyond.
Professor Paul Moss, OBE, FMedSci
Deputy Head of the College of Medical & Dental Sciences and Professor of Haematology, University of Birmingham, UK
Professor Paul Moss is a world leader in human immunology and immunotherapy. He is Deputy Head of the College of Medical and Dental Sciences and Professor of Haematology at the University of Birmingham. In recognition of his contributions to biomedical research, Professor Moss was awarded an Officer of the Order of the British Empire (OBE) for services to immunotherapy and COVID-19 research. His research focuses on immune responses to cancer, viral infection, and transplantation, with major contributions to understanding T-cell immunity.
Professor Moss has held several prominent national leadership roles, including Chair of the Medical Research Council Infection and Immunity Board and Chair of the Cancer Research UK Clinical and Translational Research Committee. He also led the UK Coronavirus Immunology Consortium (UK-CIC), coordinating national efforts to study immune protection against COVID-19.
He has authored over 400 scientific publications in leading journals and is a Fellow of the Academy of Medical Sciences.
Professor John Neoptolemos, FMedSci
Director of Pancreatic Oncology Unit, & Professor of Surgery, University of Heidelberg, Germany
Professor John P. Neoptolemos is Professor of Surgery and Senior Research Group Leader at the University of Heidelberg, Germany, and one of the world’s leading specialists in pancreatic cancer, with more than 500 peer-reviewed publications and 85,000 scientific citations. He is an internationally recognised surgeon-scientist whose work has significantly advanced translational cancer research.
Professor Neoptolemos is the founder of European Study for Pancreas Cancer Research (ESPAC) that has led the way for internationally collaborative pancreas cancer trials and now also includes the National Cancer Institutes (NCIs) of Canada and Japan and Australia. In 1997, he established the European Registry of Hereditary Pancreatitis and Pancreatic Cancer (EUROPAC), a major resource and focus for the study of genetic pancreas diseases. He also established key UK research infrastructures and received major honors, including the European Pancreatic Club Lifetime Achievement Award and the Henry Lynch Award.
Hamid M. Said, PhD, PharmD
Distinguished Professor of Physiology & Biophysics and Medicine, University of California, Irvine (UCI) School of Medicine, USA
Hamid M. Said, PhD, PharmD, is a Distinguished Professor of Physiology & Biophysics and Medicine at the University of California, Irvine (UCI) School of Medicine. His research focuses on the molecular mechanisms of nutrient transport in the gastrointestinal tract and the physiology of vitamins, with a focus on the role and interaction between inflammation and nutrient absorption with cancer and gastrointestinal health.
Dr. Said has more than 360 peer-reviewed publications in top-tier journals.
Pr. Taoufiq Fechtali
Dean of the Faculty of Science, Meknes-Morocco
A recognized expert in Neurobiology and Physiology, Professor Taoufiq Fechtali boasts a distinguished academic career marked by a robust record of international scientific publications. His research primarily focuses on the functioning of the nervous system, the study of cerebral mechanisms, and the impact of environmental factors on biological health. Before assuming the leadership of the Faculty of Sciences in Meknes, he headed numerous research structures and coordinated international cooperation projects, placing experimental rigor and high-level publication at the core of his methodology. His work actively contributes to a deeper understanding of neurological pathologies and the development of innovative therapeutic solutions.
Pr. Mohammed Hbibi
Dean of the Faculty of medicine and pharmacy, Errachidia-Morocco
Professor Mohammed Hbibi is a distinguished figure in the Moroccan medical and academic landscape, currently serving as the Dean of the Faculty of Medicine and Pharmacy in Errachidia. A specialist in Pediatrics, his career is defined by a commitment to both clinical excellence and the strategic expansion of medical education in the DrΓ’a-Tafilalet region.
A highly regarded expert in Pediatrics and Neonatology, Professor Mohammed Hbibi possesses an extensive scientific background focused on child health and medical pathology. His research interests encompass a wide range of pediatric clinical issues, contributing to the advancement of neonatal care and the management of pediatric diseases within the Moroccan healthcare system. Prior to his deanship, he established a strong reputation as a dedicated clinician and researcher, emphasizing the importance of evidence-based medicine and the integration of specialized clinical training into the university curriculum. His scientific contributions are reflected in his participation in national medical congresses and his role in supervising medical theses that address regional health challenges.
Organizing committee
Support Committee
π§βπ« Pr. Meriame Abbassi, PhD
Β Β Β Β ποΈ ISPITS β Fez
π§βπ«Pr. Touria Zair, PhD
Β Β Β Β ποΈ UniversitΓ© Moulay Ismail (UMI) β Meknes
π§βπ«Pr. Bennacer Himmi, PhD
Β Β Β Β ποΈ ISPITS β Rabat
π§βπ«Pr. Merouane Ertel, PhD
Β Β Β Β ποΈ ISPITS β Rabat
π§βπ«Pr. El Bachir Bouhali, PhD
Β Β Β Β ποΈ UniversitΓ© Moulay Ismail (UMI) β Meknes
π§βπ«Pr. Aziz Drioiche, PhD
Β Β Β Β ποΈ ISPITS β Fez
π§βπ«Pr. Reda Kachmar, PhD
Β Β Β Β ποΈ ISPITS β Beni Mellal
π§βπ«Dr. Toufik Bouddine, PhD
Β Β Β Β ποΈ UniversitΓ© Moulay Ismail (UMI) β Meknes
π§βπ«Β Dr. Aziz Zouhri, PhD
Β Β Β Β ποΈ UniversitΓ© Moulay Ismail (UMI) β Meknes
Doctoral Committee
- π Salma Quiraouani Boucetta, UMI, Meknes
- π Younes Guennoun, UMI, Meknes
- πCharaf Eddine Kassimi, UMI, Meknes
- πFedoua Diai, UMI, Meknes
- πOumayma Rharmaoui, UMI, Meknes
- πWissal Koukouch, UMI, Meknes
- πRafik El Mernissi, UMI, Meknes
- πEric Y. Yeo, UMI, Meknes
- πHafsa Hasnai, UMI, Meknes
- πRania Moubachir,Β UMI, Meknes
Scientific Committee
π International & National Experts
π€ Pr. ABBOUSSI Oualid, PhD
ποΈ FS, Rabat
π€ Pr. Achir Khaoula, MD
ποΈ UMI, FMPE
π€ Pr. Arrouss Issam, PhD
ποΈ FMPE – UMI, Meknes
π€ Pr. Banacer Himmi, PhD
ποΈ ISPITS, Rabat
π€ Pr. Ben Mkaddem Sanae, PhD
ποΈ UM6P, Benguerir
π€ Pr. Benhallem Faouzia, PhD
ποΈ FS – UMI, Meknes
π€ Pr. Benhnini Fouad, PhD
ποΈ FS – UMI, Meknes
π€ Pr. Benomar Hakima, MD
ποΈ UIC, Casablanca
π Pr. Bertrand Liagre, PhD
ποΈ Limoges, France
π€ Pr. Bouachrine Mohamed, PhD
ποΈ FS – UMI, Meknes
π Pr. Brim Hassan, PhD
ποΈ Howard University, Washington DC, USA
π€ Pr. Chakir Said, PhD
ποΈ FS – UMI, Meknes
π€ Pr. Chaachouay Hassan, PhD
ποΈ FST Errachidia
π€ Dr. El Youssoufi Soumaya, MD
π₯ Fez
π€ Pr. Elattar Hicham, MD
ποΈ UM6P, Benguerir
π€ Pr. Elbairi Khalid, MD
ποΈ UPM6, Benguerir
π€ Pr. Elbouhali Bachir, PhD
ποΈ FS – UMI, Meknes
π€ Pr. El Haloui Noureddine, PhD
ποΈ UIT, Kenitra
π€ Pr. El Kadmiri Nadia, PhD
ποΈ Ibn Zohr University
π Pr. Edderkaoui Mouad, PhD
ποΈ CSMC & UCLA, USA
π€ Pr. Ertel Merouane, PhD
ποΈ ISPITS, Rabat
π Pr. Fahmi Hassan, PhD
ποΈ Montreal University, CHUM, Canada
π€ Pr. Fetjah Dounia, PhD
ποΈ FS – UMI, Meknes
π€ Dr. Filali Z. Younes, PhD
ποΈ FS – UMI, Meknes
π Dr. Gassama Omar, MD
π₯ Clinical, UCLA, USA
π Pr. GΓ©rard Hubert Lizard, PhD
ποΈ University of Bourgogne, Inserm, France
π€ Pr. Ghazal Hasan, PhD
ποΈ UM6SS, Casablanca
π€ Pr. Hajjaj Hassan, PhD
ποΈ FS – UMI, Meknes
π€ Pr. Hajji Lhoussain, PhD
ποΈ UMI, Meknes
π€ Pr. Khallouki Farid, PhD
ποΈ FST, Errachidia
π€ Khaoula Achir, PhD
ποΈ FMPE, Errachidia
π€ Pr. Louati Sara, PhD
ποΈ FMP-UM5, Rabat
π€ Maryam El Khayari, PhD
ποΈ FMPE, Errachidia
π€ Pr. Mazouz Hamid, PhD
ποΈ FS – UMI, Meknes
π€ Pr. Meriame Abbassi, PhD
ποΈ ISPITS, Fez
π€ Pr. Mkaddem Sanae Ben, PhD
ποΈ UM6P, Benguerir
π Pr. Moss Paul, MD
ποΈ University of Birmingham, UK
π Pr. Murali Ramachandran, PhD
ποΈ CSMC, USA
π Pr. Neoptolemos John, MD
ποΈ University of Heidelberg, Germany
π Pr. Pandol Stephen, MD
ποΈ UCLA, USA
π€ Pr. Remmali Said, PhD
ποΈ FS – UMI, Meknes
π€ Pr. Rour El Habib, PhD
ποΈ FS – UMI, Meknes
π€ Pr. Sefiani Majida, PhD
ποΈ FS – UMI, Meknes
π€ Pr. Senhaji Lamiyae, MD
π₯ Hassan II CHU & USMBA, Fez
π€ Pr. Senhaji Nadia, PhD
ποΈ UMI, Meknes
π Pr. Simoes Bruno, PhD
ποΈ University of Manchester, UK
π Pr. Susaki Etsuo, A., M.D., Ph.D.
ποΈ Juntendo University, Tokyo, Japan
π€ Pr. Touria Zair, PhD
ποΈ UMI, Meknes
π€ Pr. Zaki Hanane, PhD
ποΈ EST, Khenifra
π Dr. Zayou Fouzia, PhD
ποΈ University of Manchester, UK
